Clinical Trial

A Phase IIa Study in Primary IgA Nephropathy Patients

Name: A Phase IIa Study in Primary IgA Nephropathy Patients — clinical trial record (NCT07634744)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 2

View on ClinicalTrials.gov →

Summary

This is a phase IIa, multicenter, single-arm, open-label study to evaluate the safety and efficacy of XH-S003 in patients with primary IgA nephropathy

Trial Details

NCT Number	NCT07634744
Lead Sponsor	S-INFINITY Pharmaceuticals Co., Ltd
Conditions	IgA Nephropathy
Enrollment	25 participants
Start Date	2024-12-31
Primary Completion	2026-04-23 (estimated)
Study Completion	2026-04-23 (estimated)
Updated on ClinicalTrials.gov	2026-06-09